Gastrointestinal Necrosis, CTCAE

MedGen UID:: 324180
•Concept ID:: C1556477
•: Finding

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVGastrointestinal Necrosis, CTCAE

Pathological Conditions, Signs and Symptoms
- Clinical finding
  - Finding by Cause
    - Adverse Event
      - Adverse Event by CTCAE Category
        Adverse Event Associated with the Gastrointestinal System
        Gastrointestinal Necrosis, CTCAE
        Anus Necrosis, CTCAE
        Grade 3 Anus Necrosis, CTCAE
        Grade 4 Anus Necrosis, CTCAE
        Grade 5 Anus Necrosis, CTCAE
        Colon or Cecum or Appendix Necrosis, CTCAE
        Grade 3 Colon or Cecum or Appendix Necrosis, CTCAE
        Grade 4 Colon or Cecum or Appendix Necrosis, CTCAE
        Grade 5 Colon or Cecum or Appendix Necrosis, CTCAE
        Duodenum Necrosis, CTCAE
        Grade 3 Duodenum Necrosis, CTCAE
        Grade 4 Duodenum Necrosis, CTCAE
        Grade 5 Duodenum Necrosis, CTCAE
        Esophagus Necrosis, CTCAE
        Grade 3 Esophagus Necrosis, CTCAE
        Grade 4 Esophagus Necrosis, CTCAE
        Grade 5 Esophagus Necrosis, CTCAE
        Gallbladder Necrosis, CTCAE_3
        Grade 3 Gallbladder Necrosis, CTCAE
        Grade 4 Gallbladder Necrosis, CTCAE
        Grade 5 Gallbladder Necrosis, CTCAE
        Hepatic Necrosis, CTCAE_3
        Grade 3 Hepatic Necrosis, CTCAE
        Grade 4 Hepatic Necrosis, CTCAE
        Grade 5 Hepatic Necrosis, CTCAE
        Ileum Necrosis, CTCAE
        Grade 3 Ileum Necrosis, CTCAE
        Grade 4 Ileum Necrosis, CTCAE
        Grade 5 Ileum Necrosis, CTCAE
        Jejunum Necrosis, CTCAE
        Grade 3 Jejunum Necrosis, CTCAE
        Grade 4 Jejunum Necrosis, CTCAE
        Grade 5 Jejunum Necrosis, CTCAE
        Oral Necrosis, CTCAE
        Grade 3 Oral Necrosis, CTCAE
        Grade 4 Oral Necrosis, CTCAE
        Grade 5 Oral Necrosis, CTCAE
        Pancreas Necrosis, CTCAE
        Grade 3 Pancreas Necrosis, CTCAE
        Grade 4 Pancreas Necrosis, CTCAE
        Grade 5 Pancreas Necrosis, CTCAE
        Peritoneal Necrosis, CTCAE
        Grade 3 Peritoneal Necrosis, CTCAE
        Grade 4 Peritoneal Necrosis, CTCAE
        Grade 5 Peritoneal Necrosis, CTCAE
        Pharyngeal Necrosis, CTCAE
        Grade 3 Pharyngeal Necrosis, CTCAE
        Grade 4 Pharyngeal Necrosis, CTCAE
        Grade 5 Pharyngeal Necrosis, CTCAE
        Rectal Necrosis, CTCAE
        Grade 3 Rectal Necrosis, CTCAE
        Grade 4 Rectal Necrosis, CTCAE
        Grade 5 Rectal Necrosis, CTCAE
        Small Bowel Necrosis, CTCAE
        Grade 3 Small Bowel Necrosis NOS, CTCAE
        Grade 4 Small Bowel Necrosis NOS, CTCAE
        Grade 5 Small Bowel Necrosis NOS, CTCAE
        Stoma Necrosis, CTCAE
        Grade 3 Stoma Necrosis, CTCAE
        Grade 4 Stoma Necrosis, CTCAE
        Grade 5 Stoma Necrosis, CTCAE
        Stomach Necrosis, CTCAE
        Grade 3 Stomach Necrosis, CTCAE
        Grade 4 Stomach Necrosis, CTCAE
        Grade 5 Stomach Necrosis, CTCAE

Recent clinical studies

Etiology

Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.

Christensen E, Pintilie M, Evans KR, Lenarduzzi M, Ménard C, Catton CN, Diamandis EP, Bristow RG
Clin Cancer Res 2009 Sep 1;15(17):5576-83. Epub 2009 Aug 25 doi: 10.1158/1078-0432.CCR-09-0245. PMID: 19706801

See all (1)

Diagnosis

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.

Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606

See all (1)

Therapy

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.

Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606

Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.

See all (2)

Prognosis

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.

Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606

Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.

See all (2)

Clinical prediction guides

Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.

See all (1)

Recent systematic reviews

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.

Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606

See all (1)

MedGen

National Center for Biotechnology Information

Send to:

Gastrointestinal Necrosis, CTCAE

Term Hierarchy

Recent clinical studies

Etiology

Diagnosis

Therapy

Prognosis

Clinical prediction guides

Recent systematic reviews

Supplemental Content

Table of contents

Practice guidelines

Recent activity